Nearly 3,000 drugs failed quality test in FY24; 282 were spurious
drug samples tested for quality, 2,988 have been declared as not of standard quality and 282 were found to be spurious, according to government data for the year 2023-2024. Prosecutions were launched in 604 cases for manufacturing, sale and distribution of spurious drugs, the data revealed.
The government has been running a major drive against spurious and substandard drugs. As per the data from the Central Drugs Standard Control Organisation (CDSCO) there are approximately 10,500 units in the country which are manufacturing different types of dosage forms and APIs.
«The govt has been carrying out raids in pharmaceutical companies in various states and those which were found to be in violation of regulations and were issued show cause notices,» said a senior person in the know.
So far, risk-based inspections have been carried in more than 500 premises. «Actions like issuance of show cause notices, stop production orders, suspension, cancellation of licenses or product licenses have been taken by the State Licensing Authorities based on these risk based inspections,» he said.
«The move was initiated by the DCGI to crack down against spurious and substandard drugs. The non compliant companies were closed down,» he further said.
Astrology
Vastu Shastra Course
By — Sachenkumar Rai, Vastu Shashtri
Artificial Intelligence(AI)
Mastering C++ Fundamentals with Generative AI: A Hands-On
By — Metla Sudha Sekhar, IT Specialist and Developer
Entrepreneurship
Boosting Startup Revenue with 6 AI-Powered Sales Automation Techniques
